Perthera, Inc. has developed a report empowering cancer patients to make informed decisions regarding their treatment options. The whole point of precision medicine is to tailor treatment to the specific needs of the patient.
The post Cancer Patients Can Now Read a Molecular Analysis of Their Cancer That They Can Understand appeared first on HealthcareNOWradio.com.